4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-19-012875
Options or other derivatives
- CEO acquired 1,500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
SETH SANDESH · CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-07-12 | Grant or award : show line 1 in the form Options to purchase common stock | +1,500,000 | $0.23 | $348,000 | 1,500,000 | D |
Loading xslF345X03/ownership.xml…